Who is sponsoring NCT02349516?

NCT02349516 is sponsored by Starr Muscle.

What condition does NCT02349516 study?

NCT02349516 studies Diabetic Retinopathy.

What drugs are being tested in NCT02349516?

Interventions: Squalamine Lactate Ophthalmic Solution 0.2%.

What is the status of NCT02349516?

NCT02349516 is currently WITHDRAWN.

Last reviewed 2016-05-31 · How we verify

A Randomized, Controlled Study of the Safety and Efficacy of Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema

NCT02349516 Phase 2 WITHDRAWN

A randomized, controlled study of the safety and efficacy of Squalamine Lactate Eye Drops in combination with Ranibizumab intravitreal injections in patients with diabetic macular edema. The study duration is 52 weeks and patients will be randomized to one of four treatment arms.

Details

Lead sponsor	Starr Muscle
Phase	Phase 2
Status	WITHDRAWN
Start date	2015-02
Completion	2015-09

Conditions

Diabetic Retinopathy

Interventions

Squalamine Lactate Ophthalmic Solution 0.2%

Primary outcomes

To explore the effect of Squalamine Lactate eye drops on Best Corrected Visual Acuity in subjects with diabetic macular edema — Mean change from baseline to Week 24
Proportion of patients gaining at least 3,4 and 5 lines in best corrected visual acuity from baseline to week 24

Countries

United States